Dyslipidemia

• FDA label_change · 2022-11-09
  FDA Approved: LIVALO — Supplemental Application (Kowa Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for LIVALO (pitavastatin calcium) from Kowa Pharmaceuticals America, updating the drug's labelin…

• FDA label_change · 2021-11-16
  FDA Approved: FENOFIBRATE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for fenofibrate from Apotex Corp., resulting in a label change for the generic product.

• FDA label_change · 2013-01-18
  FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approved a supplemental application for LIPOFEN (fenofibrate) submitted by ANI Pharmaceuticals, Inc., resulting in changes to the drug's…

• FDA label_change · 2010-04-22
  FDA Approved: VYTORIN — Supplemental Application (Organon LLC)

  The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC to update the product labeling.